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Introduction {#sec1}
============

Kinesins and dyneins are motor proteins responsible for cargo transport and delivery along microtubule tracks. Microtubule-based cargo transport is particularly important in cells with complex geometry, such as neurons ([@bib18]). The neuronal transport machinery delivers proteins, lipids, mRNA, and organelles to the distal sites, as well as controlling cargo degradation and recycling of building blocks. Various cargoes that are transported along microtubules move bidirectionally, exhibiting periods of rapid movements, pauses, and directional switches. The identification of mutations in genes encoding tubulin isoforms, motor proteins, or other components of the trafficking machinery in human patients strongly supports the view that defective cargo transport can directly trigger neurodegeneration ([@bib34]). It is therefore important to understand how cargo trafficking is initiated and how cargoes are captured at their final destinations. In addition, transport deficits might arise through various indirect mechanisms. For example, the stalling of vesicles could trigger the formation of aggregates within axons that may result in neuronal dysfunction.

Several molecular mechanisms related to microtubules, motors, and cargo interactions were shown to regulate cargo pick-up and delivery ([@bib32], [@bib42]). On one hand, microtubule orientation, length, and spacing in axons and dendrites can control cargo sorting and transport efficiency ([@bib20], [@bib55]). Additional motor-microtubule mechanisms include tubulin posttranslational modifications (PTMs), microtubule-associated proteins (MAPs), and tubulin isotypes ([@bib14], [@bib45]). On the other hand, transport is regulated on the site of motor-cargo interaction through motor interaction with phospholipids, receptors or integral membrane proteins, scaffolding proteins, and small Rab guanosine triphosphatase (GTPases) and their effector proteins ([@bib32], [@bib42]). Moreover, local subcellular specializations and compartmentalization of specific structures can control local cargo trafficking. For instance, the axon initial segment (AIS) functions as a cargo filter that selectively prevents passage of dendritic vesicles while allowing the entry of axonal cargoes ([@bib24]). Furthermore, evidence suggests that during transient microtubule polymerization into dendritic spines, kinesin motors transport cargoes along microtubules (MTs) into spines ([@bib10], [@bib33]). Despite growing evidence of transport regulation, little is known about how vesicles are loaded on motors and captured at the dendritic spines.

KIF1A, named UNC-104 in *Caenorhabditis elegans (C. elegans)* and *Drosophila,* was identified as the primary motor protein first for synaptic vesicles (SVs) ([@bib38], [@bib40]) and later for dense core vesicles (DCVs) ([@bib2], [@bib27], [@bib56]). DCVs, also called secretory vesicles or post-Golgi vesicles, are transported from the Golgi apparatus to the plasma membrane in both axons and dendrites, unlike SVs ([@bib8], [@bib28]). DCVs contain secretory proteins such as brain-derived neurotrophic factor (BDNF) and neuropeptide Y (NPY) and do not coincide with membrane protein transferrin receptor (TfR) ([@bib26]). The integral membrane protein synaptotagmin 4 (Syt4) is also present on DCVs ([@bib9]). The scaffolding protein liprin-α interacts with the tail region of KIF1A ([@bib43]), and liprin-α mutants in *Drosophila* impair cargo trafficking, suggesting that liprin-α is part of the KIF1A-cargo complex ([@bib35]). However, in *C. elegans,* liprin-α is mainly localized to synaptic sites, and its distribution is not affected in KIF1A mutants ([@bib44]). An additional model suggests that liprin-α can play an active role in clustering KIF1A-transported SVs ([@bib47], [@bib49]). Thus, whether liprin-α is a cargo adaptor linking KIF1A to vesicles or captures KIF1A-driven cargo to synaptic sites remains an open question.

To better understand how KIF1A-driven vesicle trafficking is controlled in neurons, we performed an interactome analysis of KIF1A. Based on those results, we focused on three KIF1A binding partners, the calcium binding protein calmodulin (CaM) and two synaptic scaffolding proteins: liprin-α and TANC2 (tetratricopeptide repeat, ankyrin repeat, and coiled coil containing 2). TANC2 was originally identified as a postsynaptic density (PSD)-95-interacting protein, regulating dendritic spine and synapse function ([@bib16]). TANC2 gene mutations are identified in patients with neurological disorders ranging from autism to schizophrenia ([@bib7], [@bib11], [@bib19]). To gain insights into the role of these three proteins in KIF1A-mediated transport, we used a combination of live-cell imaging and biochemical-proteomic methodology. This approach allowed us to demonstrate that calcium, acting via CaM, enhances KIF1A binding to DCVs and increases vesicle motility. In addition, we show that liprin-α and TANC2 are mainly localized in dendritic spines and recruit KIF1A-driven DCVs to synaptic sites. Altogether, our findings reveal a mechanism for pick-up and delivery of DCVs in dendrites.

Results {#sec2}
=======

Kinesin-3 Family Member KIF1A Interacts with Liprin-α and TANC2 {#sec2.1}
---------------------------------------------------------------

KIF1A contains a classical N-terminal motor domain, followed by three coiled coils, a stalk domain in the middle part, and a pleckstrin homology (PH) domain in the tail region, which in *C. elegans* is crucial for recognition of phosphatidylinositol 4,5-bisphosphate (PIP~2~) in cargo vesicle membranes ([Figure 1](#fig1){ref-type="fig"}A) ([@bib22]). To identify KIF1A interactome, we set up a systematic affinity purification-mass spectrometry (AP-MS) screening using different KIF1A tail fragments ([Figure 1](#fig1){ref-type="fig"}A). BioGFP-KIF1A fragments were expressed in HEK293 cells, purified with streptavidin beads, and incubated with brain lysates. Co-isolated proteins were then analyzed by mass spectrometry (MS). Among the list of putative interacting proteins detected with this approach, we classified candidate KIF1A binding partners with a probability \> 0.98, using SAINT (Significance Analysis of INTeractome) to score our AP-MS data ([Figure S1](#mmc1){ref-type="supplementary-material"}A; [Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}) ([@bib6]). Most identified binding partners are associated with the stalk domain of KIF1A (amino acid 657-1105), and most of them belong to the postsynaptic density (PSD) (7.82 = −log10\[corrected − p value\] Gene Ontology \[GO\], cellular component) ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). This stalk region is highly similar to MAGUK binding sites (MBSs) found in other kinesin-3 motors, such as KIF13B ([@bib58]). MBS regions mediate binding with the guanylate kinase (GK) domain, and in the case of KIF13B, MBS is required for the formation of a complex with the GK of the synaptic protein DLG1 ([@bib17], [@bib52]). Although MBS regions are highly conserved, small amino acid sequence variations could drastically change their binding specificities for different scaffolding proteins. In line with this, our results indicate that the MBS domain of KIF1A interacts with a different group of postsynaptic scaffolds compared to KIF13B, confirming high selectivity of these domains ([Figure S1](#mmc1){ref-type="supplementary-material"}A; [Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}). As part of the interactome, we detected well-known interactors of KIF1A, such as liprin-α family proteins ([@bib43]), as well as interactors such as TANC2. We observed a highly significant enrichment of TANC2 total spectral counts ([Figure 1](#fig1){ref-type="fig"}B) but not of counts for its homolog TANC1 ([Figure 1](#fig1){ref-type="fig"}C). Similarly, we found KIF1A associated only with TANC2 in our AP-MS experiment in which we immunoprecipitated TANC1 or TANC2 from rat brain extracts ([Figure 1](#fig1){ref-type="fig"}D). To validate our proteomic results, we performed affinity purification-Western blot (AP-WB) experiments in cells co-expressing bioGFP-KIF1A fragments (657-1105 and 657-1698), along with a hemagglutinin (HA)-tagged version of TANC1 and TANC2. As expected, both TANC2 and liprin-α bound the KIF1A middle fragment (657-1105), but not TANC1 ([Figures 1](#fig1){ref-type="fig"}E and 1F). Surprisingly, neither TANC2 nor liprin-α was able to bind a longer KIF1A fragment including the PH domain ([Figures 1](#fig1){ref-type="fig"}E and 1F), as shown by MS data ([Figure 1](#fig1){ref-type="fig"}B; [Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}), indicating an auto-inhibitory role of the C-terminal portion of KIF1A. As final evidence, reverse AP-WB experiments confirmed that TANC2 and liprin-α are binding partners of KIF1A ([Figures 1](#fig1){ref-type="fig"}G and 1H), and *in vitro* competition assays showed that TANC2 and liprin-α2 partially compete for the same binding site on KIF1A ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D). In addition, we pinpointed their N-terminal domains as the regions mainly involved in the binding ([Figures 1](#fig1){ref-type="fig"}I and 1J; [Figure S1](#mmc1){ref-type="supplementary-material"}F). We also found a potential association between TANC2 and liprin-α ([Figures S1](#mmc1){ref-type="supplementary-material"}G and S1H); however, it is quite likely that the two proteins only indirectly interact by binding KIF1A within a macromolecular complex. Overall, these results identify the PSD proteins liprin-α and TANC2 as interactors of KIF1A ([Figure 1](#fig1){ref-type="fig"}K).Figure 1KIF1A Binds to TANC2, Liprin-α, and CaM(A) bioGFP-KIF1A(383-881, 657-1105, 657-1698, 950-1250, 1105-1698) used to perform AP-MS experiments.(B) KIF1A interactors identified by MS. p values and spectral counts are graphically represented by colors and spheres, respectively. See also [Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B and [Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}.(C) TANC1 and TANC2 spectral counts detected by MS.(D) TANC (TANC1 Ab, PanTANC Ab, and TANC2 Ab) immunoprecipitation-MS experiments. p values and spectral counts of KIF1A are graphically represented by colors and spheres, respectively.(E) Western blots (WBs) of HA-TANC proteins and liprin-α1 in AP experiments of bioGFP-KIF1A(657-1105, 657-1698) from co-transfected HEK293 cells.(F) WB of HA-liprin-α2 in AP of bioGFP-KIF1A(657-1105, 657-1698).(G and H) WB of HA-KIF1A in AP of bioGFP-TANC2 (G) or bioGFP-liprin-α2 (H).(I) WB of HA-KIF1A in AP of full-length GFP-TANC2 and GFP-TANC2 fragments (1-832, 833-1227, 1228-1500, and 1501-1900).(J) WB of HA-KIF1A in AP of full-length GFP-liprin-α2 and GFP-liprin-α2 fragments (1-735 and 796-1257).(K) Schematic representation of KIF1A in association with the PSD scaffolding proteins TANC2 and liprin-α2 and with the calcium sensor CaM.(L) WB of HA-CaM in AP of bioGFP-KIF1A fragments (657-1105, 1105-1698, and 657-1698).

Kinesin-3 Family Member KIF1A Interacts with CaM {#sec2.2}
------------------------------------------------

Among other identified candidate KIF1A interactors, we decided to further characterize the calcium regulator CaM. As suggested by the number of CaM spectra detected by MS ([Figure 1](#fig1){ref-type="fig"}B) and confirmed by subsequent AP-WB ([Figure 1](#fig1){ref-type="fig"}L), CaM is one of the few proteins capable of binding both the KIF1A middle tail region (657-1105) and the full tail (657-1698). Combined with CaM being calcium regulated, it represents an ideal modulator of KIF1A-based cargo trafficking ([Figure 1](#fig1){ref-type="fig"}K). Typically, calcium binding to the EF hands of CaM induces a conformational switch, which exposes the hydrophobic pockets present in the two lobes of CaM, allowing binding to target proteins ([@bib57]). To assess the ability of CaM to bind to KIF1A in response to calcium, we performed *in vitro* affinity purification (AP) assays using bioGFP-KIF1A fragments and HA-CaM in the presence of excessive calcium (2 mM) or EDTA (2 mM) ([@bib48]). Western blot (WB) analysis revealed that the amount of CaM bound to KIF1A increased by ∼50% in calcium-supplemented samples ([Figures 2](#fig2){ref-type="fig"}A and 2B), indicating a stronger association between motor protein and CaM upon calcium addition.Figure 2Ca^2+^ Promotes CaM-KIF1A Binding and Ca^2+^/CaM Modulates KIF1A Tail Conformation(A) bioGFP-KIF1A(657-1105) was expressed in HEK293 cells, purified using streptavidin pull-downs, and incubated with protein extracts of cells expressing HA-CaM in the presence of 2 mM EDTA or 2 mM Ca^2+^. bioGFP-KIF1A(1105-1698) was used as negative control. Western blot detection was performed using HA and GFP antibodies.(B) Quantification of CaM relative intensities shown in (A), calculated as the ratio of HA-CaM signals normalized on the affinity-purified bioGFP-KIF1A signals. n = 3 experiments per condition. The bars show mean ± SEM.(C) bioGFP-KIF1A fragments (691-752, 800-896, and 986-1054) and mutant bioGFP-KIF1A(657-1105_5^∗^Ala) (W714A, W716A, Y717A, F719A, and L722A).(D) WB of HA-CaM in AP experiments of bioGFP-KIF1A truncations (657-1105, 691-752, 800-896, and 986-1054) from co-transfected HEK293 cells.(E) WB of HA-CaM in AP of bioGFP-KIF1A(657-1105_WT) or bioGFP-KIF1A(657-1105_5^∗^Ala).(F) CaM spectral counts detected by MS in AP of bioGFP-KIF1A(657-1105_WT) or bioGFP-KIF1A(657-1105_5^∗^Ala).(G) WB of HA-TANC2 and liprin-α1 in AP of bioGFP-KIF1A(657-1105, 691-752, 800-896, 986-1054).(H) WB of HA-KIF1A(657-1105) in AP of bioGFP-KIF1A(1105-1698, 950-1250).(I) bioGFP-KIF1A(1105-1698, 950-1250, 657-1698) were incubated with protein extracts of cells expressing HA-KIF1A(657-1105) in the presence of 2 mM EDTA or 2 mM Ca^2+^. WB detection was performed using HA and GFP antibodies. Ca^2+^ increases binding affinity between KIF1A fragments.(J) bioGFP-KIF1A(1105-1698, 950-1250, 657-1698) were incubated with protein extracts of cells expressing HA-KIF1A(657-1105_WT) or HA-KIF1A(657-1105_5^∗^Ala). WB detection was performed using HA and GFP antibodies. Mutant KIF1A(657-1105_5^∗^Ala) shows reduced binding to KIF1A C-terminal fragments compared to WT.(K and L) Crosslinking-mass spectrometry (XL-MS)-based analysis of purified bioGFP-KIF1A(657-1698_WT) (K) or bioGFP-KIF1A(657-1698_5^∗^Ala) (L). Schematic maps of intra-protein crosslinks are identified. Crosslinks detected in both WT and 5^∗^Ala are represented as black lines, WT-specific crosslinks are represented as red lines, and 5^∗^Ala-specific crosslinks are represented as blue lines.

The structure of Ca^2+^-bound CaM is flexible and dynamic, allowing it to recognize and modulate the activity of its substrates. As a consequence, the consensus sequence for CaM binding motifs is not well defined. Most Ca^2+^/CaM binding substrates can be broadly characterized by a short stretch of amino acids containing a high density of positively charged and hydrophobic residues ([@bib53]). In search of potential CaM binding sites, we used two separate databases: the Calmodulin Target Database (<http://calcium.uhnres.utoronto.ca>) ([@bib54]) and the Calmodulation Database and Meta-Analysis website (<http://cam.umassmed.edu>) ([@bib36]). This analysis revealed the existence of a conserved binding motif for CaM spanning residues 710--740 of KIF1A ([Figure 2](#fig2){ref-type="fig"}C). Therefore, we generated different KIF1A fragments of ∼60 amino acids each ([Figure 2](#fig2){ref-type="fig"}C) and found that KIF1A(691-752) interacted with CaM ([Figure 2](#fig2){ref-type="fig"}D). Consequently, we made a CaM binding-deficient bioGFP-KIF1A(657-1105) fragment by substituting five hydrophobic amino acids with alanine residues, as reported previously ([Figure 2](#fig2){ref-type="fig"}C) ([@bib25]). The absence of HA-CaM signal and of CaM spectra in the bioGFP-KIF1A_5^∗^Ala pull-downs indicates that the hydrophobic residues are required for CaM recognition ([Figures 2](#fig2){ref-type="fig"}E and 2F). Altogether, these results indicate that CaM interacts with a short KIF1A fragment (691-752), in contrast to TANC2 and liprin-α, which require the entire region (657-1105) to associate with KIF1A ([Figure 2](#fig2){ref-type="fig"}G) and do not compete with CaM for KIF1A binding ([Figures S1](#mmc1){ref-type="supplementary-material"}C--S1E).

CaM Binding to KIF1A Changes Intramolecular Interactions {#sec2.3}
--------------------------------------------------------

Next, we wanted to address the question of the loss of KIF1A binding partners in the full-length fragment. As described earlier, TANC2 and liprin-α are able to bind to KIF1A(657-1105), but not to the longer fragment KIF1A(657-1698) ([Figures 1](#fig1){ref-type="fig"}B, 1E, and 1F; [Figure S1](#mmc1){ref-type="supplementary-material"}A). One possible explanation is the presence of an inhibitory mechanism caused by the intramolecular interactions. To assess this, we performed AP-WB experiments using different bioGFP-KIF1A truncations, in combination with HA-KIF1A(657-1105). We only detected binding between HA-KIF1A(657-1105) and bioGFP-KIF1A(1105-1698), confirming an intramolecular interaction between the C terminus and the middle part of the tail ([Figure 2](#fig2){ref-type="fig"}H). This interaction is regulated by Ca^2+^/CaM binding ([Figures 2](#fig2){ref-type="fig"}I and 2J). To further characterize these intramolecular interactions, we applied crosslinking-mass spectrometry (XL-MS) to KIF1A(657-1698_WT) and mutant KIF1A(657-1698_5^∗^Ala). We detected nine intramolecular crosslinked peptides, of which 6 peptides were shared between the two proteins (in black) ([Figures 2](#fig2){ref-type="fig"}K and 2L). Three of those crosslinks were specific for either KIF1A-wild-type (WT) (highlighted in red) or KIF1A_5^∗^Ala (in blue). In the KIF1A_5^∗^Ala mutant, crucial intramolecular interactions were disturbed compared to the WT protein. In particular, crosslink 1044-1562 was not present in the absence of CaM and aberrant intramolecular crosslinks 720-1562 and 720-1684 were detected, confirming that the backfolding of the tail is governed by CaM binding.

Ca^2+^/CaM Regulates the Binding of KIF1A with DCVs {#sec2.4}
---------------------------------------------------

Altogether, our results highlight the importance of Ca^2+^/CaM in regulating KIF1A molecular dynamics. In the following steps, we decided to repeat our initial KIF1A AP-MS experiments in rat brain extracts, this time supplemented with either calcium or EDTA ([Figures 3](#fig3){ref-type="fig"}A--3C). The number of spectra detected for co-precipitated liprin-α and TANC2 markedly decreased in samples treated with calcium when compared to the EDTA condition ([Figures 3](#fig3){ref-type="fig"}A and 3C; [Figure S2](#mmc1){ref-type="supplementary-material"}A), suggesting that calcium negatively affects the binding affinity of KIF1A for these scaffolds. Consistent with the *in vitro* AP data ([Figures 2](#fig2){ref-type="fig"}A and 2B), we detected more CaM spectra in the presence of calcium compared to the EDTA condition ([Figures 3](#fig3){ref-type="fig"}A--3C). Only in the presence of calcium KIF1A(657-1698) associated with specific DCV-related proteins such as Syt4 and synaptotagmin 11 (Syt11) ([Figures 3](#fig3){ref-type="fig"}B and 3C; [Figure S2](#mmc1){ref-type="supplementary-material"}B). We obtained the same results for other proteins involved in PIP~2~ and phosphoinositide metabolism ([Figure 3](#fig3){ref-type="fig"}C; [Figures S2](#mmc1){ref-type="supplementary-material"}C--S2E). Based on these results, we can conclude that calcium increases the binding between KIF1A and DCVs. These proteomic findings were confirmed by *in vitro* AP-WB experiments ([Figures 3](#fig3){ref-type="fig"}D--3I). Using a CaM binding-deficient KIF1A mutant (657-1698_5^∗^Ala), revealed a reduction in the amounts of co-precipitated Syt4 ([Figure 3](#fig3){ref-type="fig"}J) or Syt11 ([Figure 3](#fig3){ref-type="fig"}K), confirming a role for CaM in promoting the interaction between KIF1A tail and DCV proteins ([Figure 3](#fig3){ref-type="fig"}L). Our proteomic data did not allow us to derive any conclusion about SV-related proteins, because the number of spectra identified was not sufficient to show enrichment. Based on these considerations and taking into account that KIF1A(657-1105) was found associated with proteins enriched in the PSD ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B), we decided to further investigate the role of KIF1A in DCV trafficking in dendrites. First, we assess the role of CaM in the KIF1A-DCV interaction in hippocampal neurons. To this end, we co-expressed GFP-KIF1A_WT or GFP-KIF1A_5^∗^Ala with DCV proteins: NPY-RFP ([Figures 4](#fig4){ref-type="fig"}A and 4B) or mCherry-Syt4 ([Figures 4](#fig4){ref-type="fig"}C and 4D). KIF1A-WT co-localized with NPY and Syt4 on vesicles, whereas mutant KIF1A, which is unable to bind CaM, showed a diffuse cytoplasmic localization that did not coincide with DCVs ([Figures 4](#fig4){ref-type="fig"}A--4E). Because CaM-KIF1A binding affinity is already stimulated at low micromolar concentrations of calcium ([Figures 4](#fig4){ref-type="fig"}F and 4G) (comparable to physiological Ca^2+^ concentrations *in vivo*), we next wondered whether increasing calcium in neurons could activate KIF1A-mediated DCV transport. To test this, we increased intracellular concentration of calcium by treating neurons with bicuculline, which acutely enhances neuronal activity by inhibiting γ-aminobutyric acid (GABA) receptor activity. Bicuculline induced clustering of KIF1A and increased motility of KIF1A-NPY complexes within minutes ([Figures 4](#fig4){ref-type="fig"}H--4M). In addition, we examined the effect of calcium deprivation (BAPTA-AM treatment) on DCV motility, and BAPTA-AM-treated neurons showed lower motility of KIF1A, NPY, and Syt4 vesicles ([Figures 4](#fig4){ref-type="fig"}N--4P). These data strongly support a role for calcium in the regulation of KIF1A-DCV loading and motility in neurons. Altogether, these results indicate that binding of Ca^2+^/CaM to the KIF1A tail regulates DCV pick-up and trafficking ([Figure 3](#fig3){ref-type="fig"}L).Figure 3KIF1A Binds DCVs in a Ca^2+^/CaM-Dependent Manner(A) bioGFP-KIF1A(657-1105) was purified using streptavidin pull-downs and incubated with rat brain extracts in the presence of 2 mM EDTA or 2 mM Ca^2+^. KIF1A(657-1105) interactors were identified by MS. Mascot scores and spectral counts of selected proteins (TANC2, liprin-α, and CaM) are graphically represented by colors and spheres, respectively. See also (C) and [Figure S2](#mmc1){ref-type="supplementary-material"}A.(B) bioGFP-KIF1A(657-1698) was incubated with rat brain extracts in the presence of 2 mM EDTA or 2 mM Ca^2+^. KIF1A(657-1698) interactors were identified by MS. Mascot scores and spectral counts of selected proteins (Syt4, Syt11, and CaM) are graphically represented by colors and spheres, respectively. See also (C) and [Figures S2](#mmc1){ref-type="supplementary-material"}B--S2E.(C) Table represents the number of spectral counts detected in AP-MS experiments of bioGFP-KIF1A(657-1105) and bioGFP-KIF1A(657-1698) in the presence of 2 mM EDTA or 2 mM Ca^2+^ for selected co-purified proteins: TANC2, liprin-α, calmodulin (CaM), synaptotagmin (Syt), phosphatidylinositol 5-phosphate 4-kinase (Pip4k2), and inositol polyphosphate 5-phosphatase (Inpp5).(D and E) bioGFP-KIF1A(657-1105) was incubated with protein extracts of cells expressing HA-TANC2 (D) or HA-liprin-α2 (E) in the presence of 2 mM EDTA or 2 mM Ca^2+^. WB detection was performed using HA and GFP antibodies.(F and G) bioGFP-KIF1A(657-1698) was incubated with protein extracts of cells expressing mCherry-Syt4 (F) or mCherry-Syt11 (G) in the presence of 2 mM EDTA or 2 mM Ca^2+^. WB detection was performed using mCherry and GFP antibodies.(H and I) Quantifications of Syt4 (H) and Syt11 (I) relative intensities shown in (F) and (G), calculated as the ratio of co-purified mCherry signals normalized on the bioGFP-KIF1A. n = 3 experiments per condition. The bars show mean ± SEM.(J and K) bioGFP-KIF1A(657-1698_WT) or bioGFP-KIF1A(657-1698_5^∗^Ala) was incubated with protein extracts of cells expressing mCherry-Syt4 (J) or mCherry-Syt11 (K). WB detection was performed using mCherry and GFP antibodies.(L) Schematic model illustrating the Ca^2+^-CaM mechanism acting on the KIF1A tail, leading to DCV loading and mobilization.Figure 4KIF1A-Driven DCVs Transport Is Regulated by Ca^2+^/CaM(A) Representative dendrites of rat hippocampal neurons (11--14 DIV) co-transfected with GFP-KIF1A_WT or GFP-KIF1A_5^∗^Ala (green) with NPY-RFP (red). Arrows point to co-localizing puncta. Scale bar, 5 μm.(B) Line scans of fluorescence intensity of GFP-KIF1A and NPY-RFP channels shown in (A).(C) Dendrites of neurons co-transfected with GFP-KIF1A_WT or GFP-KIF1A_5^∗^Ala (green) with mCherry-Syt4 (red). Arrows point to co-localizing puncta. Scale bar, 5 μm.(D) Line scans of fluorescence intensity of GFP-KIF1A and mCherry-Syt4 channels shown in (C).(E) Quantifications of GFP-KIF1A_WT and GFP-KIF1A_5^∗^Ala puncta in dendrites. The bars show mean ± SEM (n = 20--28 dendrites; ^∗∗∗^p \< 0.001, t test).(F) Ca^2+^ dependence of the *in vitro* binding of CaM to KIF1A. AP of CaM (anti-CaM beads) from lysates of cells transfected with HA-KIF1A(657-1105_WT) or HA-KIF1A(657-1105_5^∗^Ala). WB detection was performed using anti-HA antibody.(G) Quantification of KIF1A binding to CaM shown in (F). The percentage of maximal binding to CaM was defined as the intensity of the co-precipitated band of KIF1A and set at 100% in 2 mM Ca^2+^. n = 3 experiments per condition. The bars show mean ± SEM.(H and I) Representative kymographs showing trajectories of GFP-KIF1A and NPY-RFP vesicles in selected neurites of co-transfected neurons pre- and posttreatment with DMSO (H) or with 40 μm of bicuculline (I).(J and K) Quantifications of trajectories of GFP-KIF1A co-localizing with NPY-RFP (see H and I) pre- and posttreatment with DMSO (J) or with bicuculline (K). The bars show mean ± SEM (n = 12 dendrites in J and n = 34 dendrites in K; ^∗∗∗^p \< 0.001, paired t test).(L) Intracellular calcium levels in a representative dendrite treated with bicuculline and visualized with the calcium indicator GCaMP6. Scale bar, 5 μm.(M) GFP-KIF1A clustering in a representative dendrite treated with bicuculline. Scale bar, 5 μm.(N--P) Quantifications of the percentage of mobile GFP-KIF1A (N), NPY-GFP vesicles (O), or mCherry-Syt4 vesicles (P) in neurons (11--14 DIV) treated with DMSO (CTR) or 10 μm of BAPTA-AM. Bars show the mean (n = 21--29 dendrites in N, n = 20--28 dendrites in O, and n = 41--50 dendrites in P; ^∗^p \< 0.05, ^∗∗^p \< 0.001, ^∗∗∗^p \< 0.001, t test).

KIF1A-Mediated DCV Trafficking Is Independent of TANC2 and Liprin-α {#sec2.5}
-------------------------------------------------------------------

Next, we were interested whether KIF1A, TANC2, and/or liprin-α can also control DCV motility. We first systematically quantified the co-localization of KIF1A with DCV markers (NPY, Syt4, and Syt11) in hippocampal neurons ([Figure 5](#fig5){ref-type="fig"}A; [Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). KIF1A showed ∼50% co-localization with NPY-, Syt4-, and Syt11-positive vesicles ([Figures 5](#fig5){ref-type="fig"}B and 5C). Next, we tested whether NPY and synaptotagmins label the same DCV population. Only 10% of the NPY-positive vesicles coincided with Syt4 or Syt11 ([Figures 5](#fig5){ref-type="fig"}D--5F; [Figures S3](#mmc1){ref-type="supplementary-material"}C and S3D). In contrast, Syt4 and Syt11 showed ∼70% co-localization ([Figures 5](#fig5){ref-type="fig"}G--5I; [Figures S3](#mmc1){ref-type="supplementary-material"}E and S3F), indicating that NPY and synaptotagmins label different subpopulations of DCVs.Figure 5DCV Dendritic Trafficking Is KIF1A Dependent and TANC2/Liprin-α Independent(A) Neurons (11--14 DIV) co-transfected with GFP-KIF1A (green), in combination with NPY-RFP, mCherry-Syt4, or mCherry-Syt11 (red). Arrows point to co-localizing puncta. Scale bar, 5 μm. See also [Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B.(B and C) Percentage of co-localizing puncta between DCV proteins and KIF1A (B), and vice versa (C). The bars show mean ± SEM (n = 19--23 dendrites).(D) NPY-GFP (green), in combination with mCherry-Syt4 or mCherry-Syt11 (red). Scale bar, 5 μm. See also [Figures S3](#mmc1){ref-type="supplementary-material"}C and S3D.(E and F) Co-localizing puncta between NPY and Syt4 or Syt11 (E), and vice versa (F). The bars show mean ± SEM (n = 21--31 dendrites).(G) Phluorin-Syt4 (green) with mCherry-Syt11 (red) or Phluorin-Syt11 (green) with mCherry-Syt4 (red). Arrows point to co-localizing puncta. Scale bar, 5 μm. See also [Figures S3](#mmc1){ref-type="supplementary-material"}E and S3F.(H and I) Co-localizing puncta between Syt4 and Syt11 (H), and vice versa (I). The bars show mean ± SEM (n = 20--27 dendrites).(J and K) Representative kymographs showing trajectories of NPY-RFP vesicles (J) or mCherry-Syt4 vesicles (K) (red) moving with GFP-KIF1A (green).(L) Representative images acquired at 10 s intervals showing NPY-GFP motility in dendrites of neurons transfected with pSuper (right) or shRNA_KIF1A (left). In the merged images, red corresponds to 0 s, blue corresponds to 10 s, and green corresponds to 20 s. Scale bar, 5 μm.(M) Quantification of the percentage of mobile NPY vesicles in neurons (11--14 DIV) co-transfected with NPY-GFP, in combination with pSuper, shRNA_KIF1A, shRNA_KIF1A + FL-HA-KIF1A, or shRNA_KIF1A + HA-KIF1A(1-1105). The bars show mean (n = 18--32 dendrites; ^∗^p \< 0.05, ^∗∗^p \< 0.001, ^∗∗∗^p \< 0.001, t test).(N and O) Quantification of the percentage of mobile DCVs in neurons (11--14 DIV) co-transfected with NPY-GFP (N) or mCherry-Syt4 (O), in combination with pSuper, shRNA_KIF1A, shRNA_TANC2, shRNA_liprin-α2-3, or shRNA_liprin-α2-3 + shRNA_TANC2. The bars show mean (n = 17--58 dendrites in N and n = 17--39 dendrites in O; ^∗∗∗^p \< 0.001, t test). See also [Figures S3](#mmc1){ref-type="supplementary-material"}J--S3L.

Second, using live-cell imaging, we assessed whether NPY and DCVs are transported by KIF1A. Kymographs of those recordings showed robust co-movement of GFP-KIF1A and NPY-RFP, as well as mCherry-Syt4-labeled vesicles ([Figures 5](#fig5){ref-type="fig"}J and 5K). Next, we tested the effect of KIF1A knockdown on NPY or Syt4 vesicle motility. DCV motility was severely affected in neurons depleted of KIF1A, with ∼50% reduction of mobile NPY-GFP- or Syt4-Cherry-positive vesicles compared to pSuper control ([Figures 5](#fig5){ref-type="fig"}L--5O). We confirmed the specificity of this result with a rescue experiment in which expression of full-length KIF1A (but not of KIF1A lacking the C-terminal PH domain) restored NPY motility ([Figure 5](#fig5){ref-type="fig"}M). These data are in line with a previously described role for KIF1A in transporting DCVs ([@bib1], [@bib26], [@bib27], [@bib33]).

Finally, we assessed whether the depletion of TANC2 and/or liprin-α also affects DCV motility. We used previously described short hairpin RNAs (shRNAs) targeting liprin-α ([@bib46]) and generated TANC2-specific shRNAs, whose efficacy was tested by quantifying the intensity of the staining of endogenous TANC2 in neurons ([Figures S3](#mmc1){ref-type="supplementary-material"}G--S3I). TANC2 or liprin-α knockdowns did not influence DCV motility, as shown by live-cell imaging of NPY or Syt4 ([Figures 5](#fig5){ref-type="fig"}N and 5O). In addition, other transport parameters, such as pausing frequency and duration, were not affected by this treatment ([Figures S3](#mmc1){ref-type="supplementary-material"}J--S3L). These data suggest that TANC2 and liprin-α are not part of the KIF1A-DCV transport complex and do not work as classical cargo-adaptor proteins.

TANC2 and Liprin-α Are Scaffolding Proteins in Dendritic Spines {#sec2.6}
---------------------------------------------------------------

To better understand the roles of TANC2 and liprin-α in KIF1A-dependent cargo trafficking, we investigated their distribution in neurons. Both proteins localized in dendrites ([Figure 6](#fig6){ref-type="fig"}A), were enriched in dendritic protrusions, and co-localized with the postsynaptic markers PSD-95 and Homer ([Figures 6](#fig6){ref-type="fig"}B--6D). When co-expressed, TANC2 and liprin-α co-clustered in dendritic spines ([Figure 6](#fig6){ref-type="fig"}E). Analysis of the truncated isoforms revealed that the C-terminal part of TANC2 (1501-1900), which includes the PDZ binding domain, is responsible for the synaptic localization ([Figure S4](#mmc1){ref-type="supplementary-material"}A). In contrast, for liprin-α, the N-terminal part (1-735) is required for the synaptic localization ([Figure S4](#mmc1){ref-type="supplementary-material"}B). We followed those observations and characterized the interactomes of TANC2 and liprin-α ([Tables S3](#mmc4){ref-type="supplementary-material"} and [S4](#mmc5){ref-type="supplementary-material"}). Based on this analysis, we identified postsynaptic density proteins (GO classification, cellular component), such as PSD-95(DLG4), SAP-97(DLG1), CASK, Scribble, Centaurin gamma2 and 3 (AGAP1 and AGAP3), and various subunits of the NMDA receptor (Grin1 and Grin2B), as the main interactors of TANC2 ([Figure S4](#mmc1){ref-type="supplementary-material"}C; [Table S3](#mmc4){ref-type="supplementary-material"}). These results are in line with previous findings that describe TANC2 as a synaptic scaffold, interacting and co-localizing with the synaptic anchoring proteins PSD-95 and Homer ([@bib16]) and with other PDZ domain proteins ([@bib12]). Among the interacting partners of liprin-α2, we picked up both postsynaptic (Grip1, Grip2, Lin7, Trio, and CASK) ([@bib51]) and pre-synaptic proteins (Rims1/2, ERC1/2, and Munc13-1/2) involved in the maturation, docking and secretion of SVs and known to form macromolecular protein complexes with liprin-α in the axonal active zone ([Figure S4](#mmc1){ref-type="supplementary-material"}D; [Table S4](#mmc5){ref-type="supplementary-material"}) ([@bib41], [@bib46]). Altogether, we can conclude that TANC2 and liprin-α are enriched in dendritic spines and interact with various synaptic proteins.Figure 6TANC2 and Liprin-α2 Are PSD Scaffolds that Localize in Dendritic Spines(A) Hippocampal neurons (11--14 DIV) transfected with GFP-TANC2 or GFP-liprin-α2 (green) and stained for MAP2 (red). Scale bar, 20 μm.(B and C) GFP-TANC2 (B) or GFP-liprin-α2 (C) (green) co-localization with Homer and PSD-95 (red) in dendritic spines. Scale bar, 5 μm.(D) Quantifications corresponding to the percentage of GFP-TANC2 (B) or GFP-liprin-α2 (C) puncta co-localizing with PSD-95 or Homer. The bars show mean ± SEM (n = 24--36 dendrites).(E) Neurons co-expressing GFP-liprin-α2 and RFP-TANC2. Scale bar, 20 μm. Bottom panels correspond to higher magnification showing TANC2 and liprin-α2 co-localization in dendritic spines. Arrows point to co-localizing puncta. Scale bar, 5 μm.(F) Dendritic protrusions of pSuper or TANC2-KD (knockdown) neurons (shRNA_TANC2\#1, shRNA_TANC2\#3, and shRNA_TANC2mix) co-transfected with MARCKS-GFP to visualize membrane morphology. Scale bar, 5 μm. Graphs show quantifications of protrusion density (number of protrusions per 10 μm) for total number of protrusions (left) or mushroom-shaped protrusions (right). The bars show mean ± SEM (n = 30--33 dendrites; ^∗^p \< 0.05, ^∗∗∗^p \< 0.001, t test).(G) Dendritic protrusions in neurons co-transfected with pSuper, shRNA_TANC2\#1, or shRNA_TANC2\#1 + GFP-TANC2, in combination with MARCKS-GFP. Scale bar, 5 μm. The bars show mean ± SEM (n = 54--75 dendrites, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, t test).(H) Dendritic protrusions in neurons transfected with pSuper, shRNA_KIF1A, shRNA_TANC2, shRNA_liprin-α2-3, or shRNA_liprin-α2-3 + shRNA_TANC2, together with MARCKS-GFP. Scale bar, 5 μm. The bars show mean ± SEM (n = 30--36 dendrites, ^∗∗∗^p \< 0.001, t test).

TANC2, KIF1A, and Liprin-α Depletion Affects Spine Density and Morphology {#sec2.7}
-------------------------------------------------------------------------

Spine morphology is largely controlled by actin dynamics. Identifying TANC2 and liprin-α as enriched in dendritic spines led us to speculate that their distribution and accumulation may also be regulated by actin. Therefore, we transfected neurons with GFP-TANC2 or GFP-liprin-α2 and treated them with either latrunculin B to depolymerize the actin cytoskeleton or jasplakinolide to stabilize actin ([Figures S4](#mmc1){ref-type="supplementary-material"}E and S4F). Latrunculin B treatment reduced the number of TANC2 and liprin-α2 clusters in spines by ∼30%, whereas jasplakinolide treatment resulted in an opposite phenotype, with ∼30% increase of clusters in spines ([Figures S4](#mmc1){ref-type="supplementary-material"}G and S4H). These data suggest that the localization and clustering of TANC2 and liprin-α2 are affected by the actin cytoskeleton in dendritic spines. This hypothesis is strengthened by the ability of several TANC2- and liprin-α-interacting proteins to directly or indirectly associate with the actin cytoskeleton ([Figure S4](#mmc1){ref-type="supplementary-material"}I). To get further insights into the roles of TANC2, KIF1A, and liprin-α in dendritic spine morphology, we performed knockdown experiments. TANC2 depletion caused a significant reduction in the total number of protrusions, particularly of mushroom spines ([Figure 6](#fig6){ref-type="fig"}F), and the effect was rescued by re-introducing full-length TANC2 ([Figure 6](#fig6){ref-type="fig"}F). KIF1A and liprin-α depletion showed a similar phenotype, severely affecting the total number of dendritic protrusions ([Figure 6](#fig6){ref-type="fig"}H). These data are consistent with previous findings ([@bib16], [@bib33]) and show that TANC2, KIF1A, and liprin-α depletion affects spine number and morphology.

TANC2 and Liprin-α2 Act as Immobile Postsynaptic Posts Able to Recruit KIF1A in a Subset of Dendritic Spines {#sec2.8}
------------------------------------------------------------------------------------------------------------

Based on the preceding results, we further examined the functional relationship between KIF1A and TANC2 or liprin-α in dendritic spines. Co-expression of HA-KIF1A with GFP-TANC2 or GFP-liprin-α2 showed that ∼10% KIF1A-FL co-clustered with TANC2 and liprin-α2 in dendritic spines ([Figure 7](#fig7){ref-type="fig"}A). In contrast, KIF1A(1-1105), lacking the PH domain but containing the TANC2 and liprin-α binding region, showed a rather diffuse cytoplasmic pattern ([Figure 7](#fig7){ref-type="fig"}B). Nevertheless, we noticed accumulation of KIF1A(1-1105) in dendritic spines that co-localized with TANC2 and liprin-α2 ([Figure 7](#fig7){ref-type="fig"}B), suggesting that KIF1A can co-localize with TANC2 and liprin-α2 in spines even without cargo binding. This effect was exacerbated when these proteins were expressed in COS7 cells ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5F). Because KIF1A is a motor protein, we next examined the spatial and temporal dynamics of KIF1A, DCVs (by imaging NPY and Syt4), TANC2, and liprin-α. As we described earlier, KIF1A-, NPY-, and Syt4-positive vesicles showed high motility along the dendritic shaft. This was not the case for TANC2 and liprin-α, which were relatively static in dendritic spines ([Figures 7](#fig7){ref-type="fig"}C--7E). This finding supports our claim that TANC2 and liprin-α are not part of the KIF1A-DCV transport complex. Closer analysis of the vesicle dynamics revealed that DCVs frequently paused and stopped near TANC2- or liprin-α-positive clusters ([Figures 7](#fig7){ref-type="fig"}C--7E) and the number of DCV pauses at TANC2/liprin-α2 clusters was higher in mature neurons (17 days *in vitro* \[DIV\]) in which TANC2 and liprin-α2 were more accumulated in spines ([Figures S5](#mmc1){ref-type="supplementary-material"}G--S5K). We also found DCV accumulation in dendritic spines, and in ∼10% of the spines, DCVs co-localized with TANC2 and liprin-α2 ([Figures 7](#fig7){ref-type="fig"}F and 7G). To gain additional functional insight, we analyzed the distribution of DCVs in TANC2- or liprin-α-depleted neurons. TANC2 and liprin-α knockdown, but not Cortactin knockdown, caused a reduction of KIF1A, NPY, and Syt4 clusters in spines by ∼40% compared to control ([Figures 7](#fig7){ref-type="fig"}H--7J). Based on these results, we propose that TANC2 and liprin-α recruit KIF1A-driven DCVs to dendritic spines ([Figure 7](#fig7){ref-type="fig"}K).Figure 7TANC2 and Liprin-α Recruit KIF1A-Driven DCVs in Dendritic Spines(A and B) Neurons co-expressing GFP-TANC2 or GFP-liprin-α2 (green), in combination with HA-KIF1A (A) or HA-KIF1A(1-1105) (B) (red) and stained for MAP2 (blue). Scale bar, 10 μm. Panels on the right correspond to higher magnifications showing dendritic TANC2 and liprin-α2 puncta co-localizing with KIF1A. Scale bar, 5 μm.(C) Kymographs showing trajectories of GFP-KIF1A and RFP-TANC2 in a selected dendritic region of transfected hippocampal neurons (11--14 DIV).(D) Trajectories of NPY-RFP (green) vesicles pausing at GFP-liprin-α2 (red) clusters (left panel); trajectories of NPY-GFP (green) vesicles pausing at RFP-TANC2 (red) clusters (right panel).(E) mCherry-Syt4 (red) vesicles pausing at GFP-liprin-α2 (green) clusters (left panel) or at GFP-TANC2 (green) clusters (right panel).(F and G) GFP-TANC2 (F) or GFP-liprin-α2 (G) co-localizing with NPY-RFP, mCherry-Syt4, or mCherry-Syt11 puncta in dendritic protrusions visualized with MARCKS-BFP. Scale bar, 2 μm.(H--J) Quantifications showing the percentage of GFP-KIF1A (H), NPY-GFP (I), and mCherry-Syt4 (J) puncta in dendritic protrusions, measured in neurons transfected with pSuper, shRNA_Cortactin, shRNA_TANC2, and shRNA_liprin-α2-3 (11--14 DIV) and filled with MARCKS-BFP. The bars show mean ± SEM (n = 30--57 dendrites in H, n = 35--71 dendrites in I, and n = 43--90 dendrites in J; ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, t test).(K) Hypothetical model of KIF1A-dependent transport of DCVs in dendritic spines. KIF1A, in low Ca^2+^, is in an auto-inhibited conformation, unable to efficiently bind any cargo. In the presence of high Ca^2+^, KIF1A interacts with CaM, resulting in a conformational change of its C-terminal tail. Upon Ca^2+^/CaM binding, KIF1A is activated, allowing for DCV loading and motility. KIF1A-driven DCVs are recruited in dendritic spines by liprin-α and TANC2, which ensure a precise mechanism of synaptic tagging for the vesicles.

TANC2 Disease Mutations Abolish the Interaction with KIF1A and Affect KIF1A-DCV Recruitment {#sec2.9}
-------------------------------------------------------------------------------------------

The preceding findings on the role of TANC2 in DCV transport turned our interest into potential consequences for neuronal dysfunction. TANC2 gene mutations R760C and R1066X (nonsense mutation) were found in patients with intellectual disorders and autism spectrum disorder, respectively ([@bib7], [@bib19]). In the last part, we wanted to test whether those mutants may be affecting TANC2 localization to dendritic spines and/or its ability to bind KIF1A. While the localization of TANC2-R760C was similar to the WT TANC2, TANC2-R1066X failed to accumulate at the dendritic spines ([Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B). These results are in agreement with an important role of the C-terminal PDZ binding domain for TANC2 synaptic localization ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Furthermore, AP-WB experiments revealed strongly reduced binding between both TANC2 mutants and KIF1A ([Figure S6](#mmc1){ref-type="supplementary-material"}C).

To directly assess the effect of TANC2 point mutation (R760C) on KIF1A and DCV transport, we next produced chimeric proteins, which are the result of the fusion between NF186 (Neurofascin) and TANC2(1-832_WT) or TANC2(1-832_R760C). As expected, both Neurofascin-fusion proteins mis-accumulate TANC2 at the AIS ([Figures S6](#mmc1){ref-type="supplementary-material"}D and S6E). Neurons co-expressing a WT TANC2 chimera showed reduced run length ([Figure S6](#mmc1){ref-type="supplementary-material"}F), speed ([Figure S6](#mmc1){ref-type="supplementary-material"}G), and run duration ([Figure S6](#mmc1){ref-type="supplementary-material"}H) of anterograde-transported DCVs at the AIS compared to a control NF186, whereas in the presence of a mutant R760C, DCV motility was not affected ([Figures S6](#mmc1){ref-type="supplementary-material"}F--S6H). These data suggest that a single point mutation (within the N-terminal part of TANC2) found in patients with intellectual disorders, apart from being detrimental for binding with KIF1A ([Figure S6](#mmc1){ref-type="supplementary-material"}C), drastically impairs the recruitment of KIF1A-transported vesicles in neurons. Altogether, these data suggest that the aberrant localization, the abolished interaction with KIF1A, and the deficient recruitment of KIF1A-driven vesicles of TANC2 mutants may contribute to the underlying molecular mechanisms that lead to neurological defects observed in patients.

Discussion {#sec3}
==========

Ca^2+^/CaM Interacts with KIF1A and Allows DCV Binding and Motility {#sec3.1}
-------------------------------------------------------------------

In neurons, calcium is a regulatory factor for multiple elements of the trafficking machinery. Calcium and calcium-activated proteins control motor protein processivity and motor-cargo binding ([@bib18], [@bib42]). For example, Ca^2+^/CaM allows activation of actin-based motors, such as myosin Va ([@bib23]), myosin VI ([@bib3]), and myosin 1C ([@bib30]). In those cases, calcium is required for an initial activation of the myosin motor protein, allowing the transition from a backfolded conformation to an active status. Another example is the activation of Ca^2+^/CaM-dependent protein kinase II (CaMKII) by calcium, which in turn phosphorylates KIF17, leading to the release of NMDA receptor-containing vesicles ([@bib13]). Finally, the regulation of mitochondrial trafficking depends on calcium. Upon calcium binding, the adaptor protein Miro interacts with the motor domain of KIF5 motors, thereby preventing its microtubule interaction and inhibiting the transport of mitochondria ([@bib31], [@bib48]). Similar to this mechanism, cytoplasmic KIF1A is in an auto-inhibited state and becomes active only upon cargo binding ([@bib15], [@bib39]). In this study, we were able to decipher the role of calcium in KIF1A-dependent vesicle trafficking. We show that Ca^2+^/CaM-dependent modulation on KIF1A allows for binding to vesicular cargo. Our results indicate that at low calcium concentrations, the tail domain of KIF1A does not bind to vesicular cargo, whereas at high calcium concentrations, CaM binds KIF1A, allowing for subsequent DCV motility. Thus, we propose a mechanism in which Ca^2+^/CaM regulates the loading of DCVs. This model potentially represents a more general paradigm for other kinesins and cargoes in response to calcium. For example, KIF1Bβ contains a predicted CaM binding site in a highly conserved region and therefore could undergo similar Ca^2+^/CaM-dependent dynamics.

TANC2 and Liprin-α Capture KIF1A-Driven DCVs {#sec3.2}
--------------------------------------------

Syt4 is present on DCVs and is transported by KIF1A along microtubules in the dendritic shaft ([@bib1]). Microtubule entry into dendritic spines was proposed as a mechanism of local delivery of KIF1A-mediated DCVs ([@bib33]). Our data point to two scaffolding proteins, TANC2 and liprin-α, present in dendritic spines as important players in the mechanism behind KIF1A-transported DCV capture. First, TANC2 and liprin-α bind the stalk domain of KIF1A. Second, they are stably present in dendritic spines while not being part of the KIF1A-cargo complex. Third, although TANC2 and liprin-α do not directly affect the motility of KIF1A-transported DCVs, they influence the cargo distribution in dendritic spines. Based on those points, we speculate that TANC2 and liprin-α, interacting with KIF1A, are able to stop and capture KIF1A-bound DCVs upon dendritic spine entry. In this model, TANC2 and liprin-α act as local signposts tethering KIF1A-transported DCVs. Consistent with our model, neurons lacking KIF1A show spine morphology defects, which can be directly caused by an altered transport of DCVs within the dendritic spines. In this study, we focused on KIF1A-dependent DCV transport in dendrites; however, the same general principles might be applied to the transport of SVs in the axonal compartment. Similar mechanisms have been described at the pre-synaptic axonal boutons, where static clusters of liprin-α can capture KIF1A-transported SVs ([@bib41], [@bib49], [@bib50]) or where actin pre-synaptic pools locally recruit DCVs ([@bib4]). Based on our biochemical results, DCV recruitment is favored by low calcium concentrations, thereby working as an opposing mechanism counteracting the Ca^2+^/CaM-induced DCV mobility. Myosin motors may play an additional role in trafficking DCVs into spines. Specifically, it was proposed that myosin V modulates DCV transport and delivery ([@bib5]) and myosin V activity is regulated by a similar Ca^2+^/CaM mechanism ([@bib29], [@bib37]). Thus, local Ca^2+^ concentrations have an important role in the modulation of DCV trafficking and delivery in and out of dendritic spines.

In summary, we propose that Ca^2+^/CaM regulates cargo pick-up and scaffolding proteins liprin-α and TANC2 recruit KIF1A-driven DCVs into spines. Our findings reveal a potential general mechanism that depends on two basic elements: calcium to load motors to cargo and specific signposts to unload cargo. Given that alterations in cargo trafficking pathways were described in several neurological diseases, our findings that some TANC2 disease mutants do not interact with KIF1A are bringing to light additional molecular targets to investigate the trafficking machinery in neuropathological disease models.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

All experiments were approved by the DEC Dutch Animal Experiments Committee (Dier Experimenten Commissie), performed in line with institutional guidelines of Utrecht University, and conducted in agreement with Dutch law (1996 Wet op de Dierproeven) and European regulations (Directive 2010/63/EU). For details, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. Female pregnant Wister rats were obtained from Janvier Laboratories. Hippocampal neurons were obtained from embryos of both genders at the embryonic day 18 (E18) stage of development.

Expression Vectors and shRNA Constructs {#sec4.2}
---------------------------------------

pebioGFP-KIF1A(657-1105, 657-1698) correspond to truncated versions of the KIF1A rat variant 2 (XM_003750741). HA-TANC2 and GFP-TANC2 were generated using FLAG-TANC2 as a template, as described in [@bib16]. The following shRNA sequences are used in this study: TANC2\#1 (5′-CCTCAGTCAAGGGTCATAT-3′) targeting rat TANC2 mRNA (XM_008768351.1), shRNA_KIF1A ([@bib21]), and shRNA_liprin-α2/α3 ([@bib46]). All other constructs were created using PCR-based strategies. For details, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Hippocampal Neuron Cultures, Transfections, and Treatments {#sec4.3}
----------------------------------------------------------

Primary hippocampal cultures were prepared from E18 rat brains. Cells were plated on coverslips coated with poly-L-lysine (30 μg/mL) and laminin (2 μg/mL) at a density of 100,000/well. Hippocampal neurons were transfected using lipofectamine (Invitrogen). Neuron cultures were treated with 10 μM latrunculin B, 10 μM jasplakinolide, 10 μM BAPTA-AM, or 40 μM bicuculline and fixed or imaged from 0 to 1 hr after addition of the drugs. For details, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

AP-MS Using Biotin or GFP Pull-Down on Rat Brain Extracts {#sec4.4}
---------------------------------------------------------

Brains were obtained from female adult rats and homogenized in tissue lysis buffer (50 mM Tris HCl, 150 mM NaCl, 0.1% SDS, 0.2% NP-40, and protease inhibitors). Brain lysates were centrifuged at 16,000 × *g* for 15 min at 4°C, and the supernatant was then incubated for 1 hr at 4°C with beads previously conjugated with the protein of interest. For details, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Sample Preparation, Peptide Fractionation, MS, and Data Analysis {#sec4.5}
----------------------------------------------------------------

All samples were analyzed on an electron transfer dissociation (ETD)-enabled LTQ-Orbitrap Elite coupled to Proxeon EASY-nLC 1000 (Thermo Fisher Scientific) or on an Orbitrap Q-Exactive mass spectrometer (Thermo Fisher Scientific) coupled to an Agilent 1290 Infinity LC (Agilent Technologies). The full MS methods are available in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Live-Cell Imaging Microscopy and Analysis {#sec4.6}
-----------------------------------------

Live-cell imaging experiments were performed in an inverted spinning disk confocal microscope equipped with a Plan Apo VC 100×/60× NA 1.40 oil objective and an incubation chamber mounted on a motorized XYZ stage, which were all controlled using MetaMorph (Molecular Devices) software. For details, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Statistical Methods {#sec4.7}
-------------------

AP-MS data were analyzed using the SAINT (Significance Analysis of INTeractions, v.2.3.2) algorithm. Statistical significance was determined using Student's t test assuming a two-tailed variation. The graphs represent mean ± SEM. For details, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Data and Software Availability {#app1}
==============================

The accession number for the mass spectrometry proteomic data reported in this paper is PRIDE: [PXD010080](pride:PXD010080){#intref0020}.

Supplemental Information {#app3}
========================

Document S1. Supplemental Experimental Procedures and Figures S1--S6Table S1. bioGFP-KIF1A(657-1105)-Interacting Proteins, Related to Figure 1Contains data from affinity purification mass spectrometry analyses (AP-MS) (two biological replica) of bioGFP-KIF1A(657-1105) in rat brain extracts. PROTID = Uniprot accession code; gene name = corresponding gene name; Description = Protein name/description derived from ^∗^.fasta database; bioGFP\_\#PSM = number of PSM from bioGFP-only control AP; bioGFP\_\#peptides = number of peptides from bioGFP-only control AP; bioGFP(657-1105)\_\#PSM = number of PSM from bioGFP-KIF1A(657-1105); bioGFP(657-1105)\_\#peptides = number of peptides from bioGFP-KIF1A(657-1105); p value = probability score from SAINT (Significance Analysis of INTeractions, version 2.3.2) (Choi et al., 2011) analysis. 0 ≤ p ≤ 1, the higher the score the higher the probability for a given interaction; SAINT probability \> 0.98 = proteins with a SAINT probability score \> 0.98 are flagged as 'TRUE'; AP-MS_HEK293_cells = value = \#N/A, means that the homologous protein has not been identified in the control (CTR) AP-MS of bioGFP-KIF1A(657-1105) in HEK293 cells / value = gene name, means that the same homologous protein has been identified in the CTR AP-MS of bioGFP-KIF1A(657-1105) in HEK293cells.Table S2. bioGFP-KIF1A(657-1698)-Interacting Proteins, Related to Figure 1Contains data from affinity purification mass spectrometry analyses (AP-MS) (two biological replica) of bioGFP-KIF1A(657-1698) in rat brain extracts. PROTID = Uniprot accession code; gene name = corresponding gene name; Description = Protein name/description derived from ^∗^.fasta database; bioGFP\_\#PSM = number of PSM from bioGFP-only control AP; bioGFP\_\#peptides = number of peptides from bioGFP-only control AP; bioGFP(657-1698)\_\#PSM = number of PSM from bioGFP-KIF1A(657-1698); bioGFP(657-1698)\_\#peptides = number of peptides from bioGFP-KIF1A(657-1698); p value = probability score from SAINT (Significance Analysis of INTeractions, version 2.3.2) (Choi et al., 2011) analysis. 0 ≤ p ≤ 1, the higher the score the higher the probability for a given interaction; SAINT probability \> 0.98 = proteins with a SAINT probability score \> 0.98 are flagged as 'TRUE'; AP-MS_HEK293_cells = value = \#N/A, means that the homologous protein has not been identified in the CTR AP-MS of bioGFP-KIF1A(657-1698) in HEK293 cells / value = gene name, means that the homologous protein has been identified in the CTR AP-MS of bioGFP-KIF1A(657-1698) in HEK293cells.Table S3. bioGFP-TANC2-Interacting Proteins, Related to Figure 6Contains data from affinity purification mass spectrometry analyses (AP-MS) (two biological replica) of bioGFP-TANC2 in rat brain extracts. PROTID = Uniprot accession code; gene name = corresponding gene name; Description = Protein name/description derived from ^∗^.fasta database; bioGFP\_\#PSM = number of PSM from bioGFP-only control AP; bioGFP\_\#peptides = number of peptides from bioGFP-only control AP; bioGFP-TANC2\_\#PSM = number of PSM from bioGFP-TANC2; bioGFP-TANC2\#peptides = number of peptides from bioGFP-TANC2; p value = probability score from SAINT (Significance Analysis of INTeractions, version 2.3.2) (Choi et al., 2011) analysis. 0 ≤ p ≤ 1, the higher the score the higher the probability for a given interaction; SAINT probability \> 0.90 = proteins with a SAINT probability score \> 0.90 are flagged as 'TRUE'; AP-MS_HEK293_cells = value = \#N/A, means that the homologous protein has not been identified in the CTR AP-MS of bioGFP-TANC2 in HEK293 cells / value = gene name, means that the homologous protein has been identified in the CTR AP-MS of bioGFP-TANC2 in HEK293 cells.Table S4. bioGFP-Liprin-α2-Interacting Proteins, Related to Figure 6Contains data from affinity purification mass spectrometry analysis (AP-MS) of bioGFP-liprin-α2 in rat brain extracts. PROTID = Uniprot accession code; gene name = corresponding gene name; Description = Protein name/description derived from ^∗^.fasta database; bioGFP\_\#PSM = number of PSM from bioGFP-only control AP; bioGFP\_\#peptides = number of peptides from bioGFP-only control AP; bioGFP-liprin-α2\_\#PSM = number of PSM from bioGFP-liprin-α2; bioGFP-liprin-α2\#peptides = number of peptides from bioGFP-liprin-α2; p value = probability score from SAINT (Significance Analysis of INTeractions, version 2.3.2) (Choi et al., 2011) analysis. 0 ≤ p ≤ 1, the higher the score the higher the probability for a given interaction; SAINT probability \> 0.99 = proteins with a SAINT probability score \> 0.99 are flagged as 'TRUE'; AP-MS_HEK293_cells = value = \#N/A, means that the homologous protein has not been identified in the CTR AP-MS of bioGFP-liprin-α2 in HEK293 cells / value = gene name, means that the homologous protein has been identified in the CTR AP-MS of bioGFP-liprin-α2 in HEK293cells.Document S2. Article plus Supplemental Information
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